May 3-4, 2017 Boston Convention & Exhibition CenterBoston, MA

BIOMEDevice Boston 2017 Schedule Viewer

Use the scheduling tool below to browse all the available sessions, speakers, and topics at this year's event. Find the content and sessions to fit all of your educational needs and ensure you get the most out of your time at the event.
All SessionsSpeakersMy Schedule
View Sessions As:
  
  • Charles Bridges, MD, ScDGlobal VP, CV Therapeutic Area ExpertJohnson and Johnson Medical Device Companies

    Charles R. Bridges is the Global Vice President, Cardiovascular Therapeutic Area Expert for Medical Devices. In this role, he accelerates innovation, and advances the standard of care within early stage science to elevate existing and adjacent technologies.

    Charles is a board certified cardiothoracic surgeon and is an internationally recognized expert in cardiovascular gene therapy, blood conservation and transfusion-free cardiac surgery. He is responsible for identifying new technology platforms in cardiovascular devices that provide transformational innovation. Charles joined Johnson & Johnson from Carolinas Healthcare System where he was Chairman of the Department of Thoracic and Cardiovascular Surgery and Vice President of Cardiovascular Translational Research. He was previously Professor of Surgery at the University of Pennsylvania and Chief of Cardiac Surgery at Pennsylvania Hospital. A surgeon-scientist, he invented the concept of "molecular cardiac surgery". Charles has received more than $10M in NIH funding and has over 160 peer-reviewed publications, twelve issued and pending U.S. and international patents for inventions in the fields of cardiovascular devices and cardiac and systemic gene and cell delivery. He has served as a consultant to the Circulatory System Devices Panel of the U.S. Food and Drug Administration and as a regular member of the Bioengineering, Technology and Surgical Sciences Study Section of NIH. He currently serves as a member of the Steering Committee of the Gene Therapy Resource Program (GTRP) of the National Heart Lung and Blood Institute, and as Chairman of the Cardiovascular Committee of the American Society for Cell and Gene Therapy.

    Charles received an A.B. in Applied Physics from Harvard College magna cum laude at age 19 and an M.D. from Harvard Medical School in the Harvard-M.I.T. Program in Health Sciences and Technology. He received a Master of Science in Electrical Engineering and Computer Science and a Doctor of Science in Chemical Engineering from M.I.T. where he was elected to Sigma Xi as a Whittaker Health Sciences Fellow. He competed in the 2016 World (Rubik's) Cube Association US Nationals competition.


    Presenting: